The Patent Finder

Athena Neurosciences, Inc.

Also on record
Records under this name other than patents Athena Neurosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Athena Neurosciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,982,084Prevention and Treatment of Amyloidogenic Disease
Formerly held
Term ended
Ended no later than Sep 23, 2019 · Low confidence
Term endedEnded no later than Sep 23, 2019Low confidence
US 7,166,580Compounds Which Inhibit Leukocyte Adhesion Mediated by VLA-4
Formerly held
Term ended
Term ended Sep 15, 2019 · Medium confidence
Term endedTerm ended Sep 15, 2019Medium confidence
US 6,787,140Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Ended no later than Jun 26, 2019 · USPTO record
Term endedEnded no later than Jun 26, 2019USPTO record
US 7,014,855Prevention and Treatment of Amyloidogenic Disease
Formerly held
Term ended
Term ended May 30, 2019 · Medium confidence
Term endedTerm ended May 30, 2019Medium confidence
US 6,866,850Prevention and Treatment of Amyloidogenic Disease
Formerly held
Term ended
Term ended Mar 17, 2019 · Medium confidence
Term endedTerm ended Mar 17, 2019Medium confidence
US 6,787,138Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Term ended Jan 16, 2019 · USPTO record
Term endedTerm ended Jan 16, 2019USPTO record
US 6,787,139Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Ended no later than Nov 30, 2018 · USPTO record
Term endedEnded no later than Nov 30, 2018USPTO record
US 6,787,143Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Ended no later than Nov 30, 2018 · USPTO record
Term endedEnded no later than Nov 30, 2018USPTO record
US 6,787,144Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Ended no later than Nov 30, 2018 · USPTO record
Term endedEnded no later than Nov 30, 2018USPTO record
US 6,787,523Prevention and treatment of amyloidogenic disease
Formerly held
Term ended
Ended no later than Nov 30, 2018 · USPTO record
Term endedEnded no later than Nov 30, 2018USPTO record
10 of 104 patents shown.
Pro members see all 104.
Pro members: see all 104 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited